Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Okui

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Annals of Surgical Oncology|December 17, 2022
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgical Oncology|June 1, 2023
Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide StudyAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgery|December 20, 2022
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaSatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 20, 2023
Old age and intense chemotherapy exacerbate negative prognostic impact of postoperative complication on survival in patients with esophageal cancer who received neoadjuvant therapy: a nationwide study from 85 Japanese esophageal centersSatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 8, 2023
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Esophagus : Official Journal of the Japan Esophageal Society|March 25, 2023
Prognostic impact of endoscopic response evaluation after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a nationwide validation studySatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Clinical and Translational Science|December 2, 2024
Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitorsJun Okui, Takashi Waki, Kazuhiro Kajiyama, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 18, 2025
Investigating the synergistic effects of immunochemotherapy in esophageal squamous cell carcinomaJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 25, 2025
Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinomaRyota Kobayashi, Satoru Matsuda, Kohei Nakamura, et al.
Journal of Gastric Cancer|July 9, 2025
Investigating the Synergistic Effects of Pembrolizumab and Chemotherapy in Gastric and Gastroesophageal Junction CancerJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|December 17, 2022
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgical Oncology|June 1, 2023
Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide StudyAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgery|December 20, 2022
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaSatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 20, 2023
Old age and intense chemotherapy exacerbate negative prognostic impact of postoperative complication on survival in patients with esophageal cancer who received neoadjuvant therapy: a nationwide study from 85 Japanese esophageal centersSatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 8, 2023
Risk prediction of esophageal squamous cell carcinoma recurrence in patients who underwent esophagectomy after receiving neoadjuvant treatment: a nationwide retrospective study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Esophagus : Official Journal of the Japan Esophageal Society|March 25, 2023
Prognostic impact of endoscopic response evaluation after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a nationwide validation studySatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Clinical and Translational Science|December 2, 2024
Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitorsJun Okui, Takashi Waki, Kazuhiro Kajiyama, et al.
Esophagus : Official Journal of the Japan Esophageal Society|February 18, 2025
Investigating the synergistic effects of immunochemotherapy in esophageal squamous cell carcinomaJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 25, 2025
Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinomaRyota Kobayashi, Satoru Matsuda, Kohei Nakamura, et al.
Journal of Gastric Cancer|July 9, 2025
Investigating the Synergistic Effects of Pembrolizumab and Chemotherapy in Gastric and Gastroesophageal Junction CancerJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Pageof 5